Keyword Connections

blood-brain barrier

Journals

14

1 bioorganic & medicinal chemistry

2 Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

3 Brain research

4 The Journal of organic chemistry

5 Bioorganic & medicinal chemistry letters

6 Theranostics

7 Journal of Alzheimer's disease : JAD

8 Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

9 Multiple sclerosis and related disorders

10 Pharmaceutical research

11 Journal of neuroinflammation

12 translational stroke research

13 current neurovascular research

14 GeroScience

Research Groups

0

No Research Group Connected

Bibliographies

67

1 Neuroprotective effect of Vanillin on hypoxic-ischemic brain damage in neonatal rats.

2 NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral hemorrhage in mice.

3 Role of granulocyte colony-stimulating factor in protection of cerebral vascular endothelium, white matter, and cognition.

4 Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging.

5 Activation of the Hedgehog Pathway Promotes Recovery of Neurological Function After Traumatic Brain Injury by Protecting the Neurovascular Unit.

6 Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients.

7 Disruption of blood-brain barrier integrity associated with brain lesions in Chinese neuromyelitis optica spectrum disorder patients.

8 Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease.

9 Cobalt/Copper-Cocatalyzed Synthesis of Imidazo[1,2-a:3,4-a']dipyridiniums from 2H-[1,2'-Bipyridin]-2-ones and 2-Bromoacetophenones.

10 the role of bile pigments in health and disease: effects on cell signaling, cytotoxicity and cytoprotection

11 blood-brain transfer of pittsburgh compound b in humans

12 perlecan and the blood-brain barrier: beneficial proteolysis?

13 hemostazni sistem i ishemijska bolest mozga (opšti aspekt)

14 immune responses at brain barriers and implications for brain development and neurological function in later life

15 dissecting gene expression at the blood-brain barrier

16 clinical features and experimental models of cerebral small vessel disease

17 commentary: central-acting therapeutics alleviate respiratory weakness caused by heart failure–induced ventilatory overdrive

18 pegylated liposomal doxorubicin-induced acute transient encephalopathy in a patient with breast cancer: a case report

19 proposed toxic and hypoxic impairment of a brainstem locus in autism

20 neuroinflammation and infection: molecular mechanisms associated with dysfunction of neurovascular unit

21 n-butylphthalide alleviates blood-brain barrier impairment in rats exposed to carbon monoxide

22 cerebral malaria: gamma-interferon redux

23 the metalloprotease, mpr1, engages annexina2 to promote the transcytosis of fungal cells across the blood-brain barrier

24 methamphetamine effects on blood-brain barrier structure and function

25 pseudopterosin a: protection of synaptic function and potential as a neuromodulatory agent

26 the role of abcb1 and abca1 in beta-amyloid clearance at the neurovascular unit in alzheimer’s disease

27 mechanical injury induces brain endothelial-derived microvesicle release: implications for cerebral vascular injury during traumatic brain injury

28 implications of mmp9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke

29 can insulin signaling pathways be targeted to transport aβ out of the brain?

30 therapeutic effects of ellagic acid on memory, hippocampus electrophysiology deficits, and elevated tnf-α level in brain due to experimental traumatic brain injury

31 inflammatory response of the spinal cord to multiple episodes of blood-brain barrier disruption and toxic demyelination in wistar rats

32 neurogenic niches in the brain: help and hindrance of the barrier systems

33 interfacing graphene-based materials with neural cells

34 Preformulation Studies of a Stable PTEN-PDZ Lipopeptide Able to Cross an In Vitro Blood-Brain-Barrier Model as a Potential Therapy for Alzheimer's Disease.

35 matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke

36 alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of ppars.

37 Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping.

38 Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo.

39 Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.

40 Maltodextrin modified liposomes for drug delivery through the blood-brain barrier.

41 Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study

42 Focused Ultrasonography-Mediated Blood-Brain Barrier Disruption in the Enhancement of Delivery of Brain Tumor Therapies

43 13C Pyruvate Transport Across the Blood-Brain Barrier in Preclinical Hyperpolarised MRI

44 The effects of Vitis vinifera L. phenolic compounds on a blood-brain barrier culture model: Expression of leptin receptors and protection against cytokine-induced damage

45 Targeting MEK/MELK in Atypical Teratoid Rhabdoid Tumour: A treatment approach aimed at exploiting blood-brain barrier deficiencies.

46 Effects of Focused-Ultrasound-and-Microbubble-Induced Blood-Brain Barrier Disruption on Drug Transport under Liposome-Mediated Delivery in Brain Tumour: A Pilot Numerical Simulation Study.

47 Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection.

48 Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study.

49 Evaluation of pharmacokinetics and blood-brain barrier permeability of mitragynine using in vivo microdialysis technique.

50 Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function.

51 High HbA level is correlated with blood-brain barrier disruption in syphilis patients.

52 Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia.

53 IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.

54 Chronic dysfunction of blood-brain barrier in patients with post-encephalitic/encephalopathic epilepsy.

55 Endothelium-targeted overexpression of krüppel-like factor 11 protects blood-brain barrier function after ischemic brain injury.

56 The characteristics of blood-brain barrier in three different conditions — infarction, selective neuronal death and selective loss of presynaptic terminals — following cerebral ischemia

57 Reduced Neuronal cAMP in the Nucleus Accumbens Damages Blood-Brain Barrier Integrity and Promotes Stress Vulnerability

58 A two-hour window for hypothermic modulation of early events that impact delayed opening of the rat blood-brain barrier after ischemia

59 Matrix Metalloproteinase (MMP)-8 and MMP-9 in Cerebrospinal Fluid during Bacterial Meningitis: Association with Blood-Brain Barrier Damage and Neurological Sequelae

60 microrna-210 suppresses junction proteins and disrupts blood-brain barrier integrity in neonatal rat hypoxic-ischemic brain injury

61 seeking a new paradigm for alzheimer’s disease: considering the roles of inflammation, blood-brain barrier dysfunction, and prion disease

62 magnetic nanoparticles cross the blood-brain barrier: when physics rises to a challenge

63 pinocembrin protects blood-brain barrier function and expands the therapeutic time window for tissue-type plasminogen activator treatment in a rat thromboembolic stroke model

64 erratum to “xiao-xu-ming decoction protects against blood-brain barrier disruption and neurological injury induced by cerebral ischemia and reperfusion in rats”

65 quantitative in vitro and in vivo evaluation of intestinal and blood-brain barrier transport kinetics of the plant n-alkylamide pellitorine

66 triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegeneration

67 expression of vegf and flk-1 and flt-1 receptors during blood-brain barrier (bbb) impairment following phoneutria nigriventer spider venom exposure